Trials / Terminated
TerminatedNCT01312675
S.A.F.E.BT System Extracorporeal Treatment With DIAPACT CRRT
Randomized, Multi-Centre, Controlled Clinical Study on Effect of the Selective Adsorption System for Removal of Bacterial Toxins (S.A.F.E.BT) Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- B. Braun Medical Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if Selective Adsorption System for Removal of Bacterial Toxins (S.A.F.E.BT) therapy is effective in the treatment of severe sepsis.
Detailed description
Is extracorporeal treatment effective in the treatment of sepsis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | S.A.F.E.BT | Five (5) S.A.F.E.BT treatments within a 7 day treatment period. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2015-03-01
- Completion
- 2015-06-01
- First posted
- 2011-03-11
- Last updated
- 2018-10-12
- Results posted
- 2018-10-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01312675. Inclusion in this directory is not an endorsement.